Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis, shadowed by data scandal, renews case for Zolgensma
Biopharma Dive
Thu, 09/19/19 - 09:56 am
Tags:
Novartis, Zolgensma, SMA, spinal muscular atrophy
Biogen ramps up its SMA rivalry with Novartis with new Spinraza trial
Fierce Pharma
Wed, 09/18/19 - 11:21 am
Tags:
Biogen, clinical trials, Spinraza, SMA, spinal muscular atrophy, Novartis
Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed
Drug Channels
Tue, 09/17/19 - 03:35 pm
Tags:
Eli Lilly, Janssen, Merck, Novartis, Sanofi, drug pricing
Novartis’ Cosentyx heads for fourth indication after supportive data in early ankylosing spondylitis
Pharmaforum
Tue, 09/17/19 - 10:18 am
Tags:
Novartis, Cosentyx, ankylosing spondylitis
Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug
Xconomy
Tue, 09/17/19 - 10:12 am
Tags:
Amplyx, Novartis, immune deficiency, MAU868
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
RAPS.org
Sun, 09/15/19 - 09:47 pm
Tags:
breast cancer, FDA, Ibrance, Kisqali, Verzenio, Pfizer, Novartis, Eli Lilly
Novartis backs brolucizumab with new head-to-head Eylea trial
Pharmaforum
Mon, 09/9/19 - 08:15 pm
Tags:
Novartis, clinical trials, brolucizumab, Eylea, Bayer, Regeneron, age-related macular degeneration
Novartis Makes New Data Integrity Commitment
RAPS.org
Mon, 09/9/19 - 11:22 am
Tags:
Novartis, data, data integrity, Vas Narasimhan, Zolgensma
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Tags:
Amgen, AMG 510, KRAS inhibitors, Roche, PTC Therapeutics, risdiplam, Eylea, Novartis
Novartis’ lung cancer drug edges closer to market after FDA grants fast review
Pharmaforum
Fri, 09/6/19 - 12:27 pm
Tags:
Novartis, Incyte, FDA, breakthrough therapy, non-small cell lung cancer
Benevolent AI and Novartis sign AI R&D deal
Pharmaforum
Fri, 09/6/19 - 10:14 am
Tags:
Novartis, BenevolentAI, artificial intelligence, oncology, cancer
With third pharma deal, IFM's unorthodox approach paying off
Biopharma Dive
Thu, 09/5/19 - 08:22 pm
Tags:
IFM Therapeutics, Novartis, Bristol-Myers Squibb
Potential buyers size up Novartis site as layoffs loom for 400 workers
Fierce Pharma
Wed, 09/4/19 - 11:24 pm
Tags:
Novartis, drug manufacturing, layoffs
UK cost watchdog recommends Novartis' blindness therapy Luxturna
Yahoo/Reuters
Wed, 09/4/19 - 10:18 am
Tags:
Novartis, gene therapy, Luxturna, UK, NICE, Spark Therapeutics
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Tags:
Novartis, Sandoz, generics, biosimilars, Tysabri, Polpharma
Novartis’ ofatumumab meets primary endpoints in two phase 3 RMS trials
Pharmaceutical Business Review
Mon, 09/2/19 - 12:24 pm
Tags:
Novartis, ofatumumab, OMB157, Aubagio, clinical trials, relapsing multiple sclerosis
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Mon, 09/2/19 - 12:19 pm
Tags:
Novartis, heart failure, Entresto, clinical trials, ESC, European Society of Cardiology
Novartis takes aim at Roche's star MS drug
Reuters
Fri, 08/30/19 - 10:08 am
Tags:
Novartis, Roche, multiple sclerosis, Arzerra, ofatumumab, Ocrevus
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
Thu, 08/29/19 - 08:18 pm
Tags:
multiple sclerosis, MS, drug pricing, Biogen, Roche, Sanofi, Novartis, Teva Pharmaceutical, Bayer
Novartis earlier acknowledged Zolgensma data errors to FDA but blamed them on poor reporting
Fierce Pharma
Tue, 08/27/19 - 12:06 pm
Tags:
Novartis, AveXis, Zolgensma, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.